Shares of ValiRx plc (LON:VAL – Get Free Report) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1.18 ($0.02) and traded as low as GBX 0.59 ($0.01). ValiRx shares last traded at GBX 0.59 ($0.01), with a volume of 438,093 shares.
ValiRx Price Performance
The company’s 50-day moving average is GBX 0.70 and its 200-day moving average is GBX 1.18. The firm has a market capitalization of £2.23 million, a price-to-earnings ratio of -0.40 and a beta of 0.59. The company has a debt-to-equity ratio of 0.44, a current ratio of 6.65 and a quick ratio of 1.27.
About ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Articles
- Five stocks we like better than ValiRx
- How to Effectively Use the MarketBeat Ratings Screener
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Alphabet’s Officially In A Bear Market—Time To Buy?
- 3 Ways To Invest In Coffee, Other Than Drinking It
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
